- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Receptor Kinases in Colorectal Cancer
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 4, Pages 433
Publisher
MDPI AG
Online
2019-03-29
DOI
10.3390/cancers11040433
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer
- (2018) Maya Jeitany et al. EMBO Molecular Medicine
- Platelet‑derived growth factor receptor‑β gene expression relates to recurrence in colorectal cancer
- (2018) Shiki Fujino et al. ONCOLOGY REPORTS
- Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer
- (2018) Akira Okita et al. Oncotarget
- Factors Associated with Prolonged Patient-Attributable Delay in the Diagnosis of Colorectal Cancer
- (2018) Irene Zarcos-Pedrinaci et al. Cancer Research and Treatment
- Inhibiting TRK Proteins in Clinical Cancer Therapy
- (2018) Allison Lange et al. Cancers
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- NCOA4-RET fusion in colorectal cancer: Therapeutic challenge using patient-derived tumor cell lines
- (2018) Sun Young Kim et al. Journal of Cancer
- 457PDKinase fusions in colorectal cancers: A unique biologic subset
- (2018) R Madison et al. ANNALS OF ONCOLOGY
- Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy
- (2018) Marilina García-Aranda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Prognostic Value of the Combination of Low VEGFR-1 and High VEGFR-2 Expression in Endothelial Cells of Colorectal Cancer
- (2018) Nicky D’Haene et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer
- (2018) Gordon C. Jayson et al. Nature Communications
- Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer
- (2017) Barbara Jung et al. GASTROENTEROLOGY
- The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)
- (2017) Fatima Ardito et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Protein Kinase Targets in Breast Cancer
- (2017) Marilina García-Aranda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of PDGFs and PDGFRs in Colorectal Cancer
- (2017) Roberta M. Manzat Saplacan et al. MEDIATORS OF INFLAMMATION
- The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer
- (2017) Diana J. Uribe et al. PLoS One
- Hepatocyte growth factor is a prognostic marker in patients with colorectal cancer: a meta-analysis
- (2017) Chao-yuan Huang et al. Oncotarget
- ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer
- (2017) Jian-Kang Zhou et al. Oncotarget
- EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function
- (2017) Ching-Wen Huang et al. Oncotarget
- Stroma-derived HGF drives metabolic adaptation of colorectal cancer to angiogenesis inhibitors
- (2017) Alessia Mira et al. Oncotarget
- Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
- (2017) Michael A. Cannarile et al. Journal for ImmunoTherapy of Cancer
- ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration
- (2016) Sean S. Q. Ma et al. BMC CANCER
- Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target
- (2016) E. Yakirevich et al. CLINICAL CANCER RESEARCH
- Molecular pathological classification of colorectal cancer
- (2016) Mike F. Müller et al. VIRCHOWS ARCHIV
- Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells
- (2016) Maryam Abbaspour Babaei et al. Drug Design Development and Therapy
- TAM receptors Tyro3 and Mer as novel targets in colorectal cancer
- (2016) Robin Schmitz et al. Oncotarget
- The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors
- (2016) Sung Hee Lim et al. Oncotarget
- Factors that influence treatment delay in patients with colorectal cancer
- (2016) Irene Zarcos-Pedrinaci et al. Oncotarget
- Portrait of the PI3K/AKT pathway in colorectal cancer
- (2015) Stine Aske Danielsen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis
- (2015) G. A. Smith et al. BIOSCIENCE REPORTS
- Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer
- (2015) Liang Hu et al. BMC CANCER
- Systematic Mapping of Kinase Addiction Combinations in Breast Cancer Cells by Integrating Drug Sensitivity and Selectivity Profiles
- (2015) Agnieszka Szwajda et al. CHEMISTRY & BIOLOGY
- c-Kit as a Novel Potential Therapeutic Target in Colorectal Cancer
- (2015) Yatrik M. Shah et al. GASTROENTEROLOGY
- Genomic Instability Causes HGF Gene Activation in Colon Cancer Cells, Promoting Their Resistance to Necroptosis
- (2015) Danushka Seneviratne et al. GASTROENTEROLOGY
- A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)
- (2015) Joanne W. Chiu et al. INVESTIGATIONAL NEW DRUGS
- Ramucirumab, another anti-angiogenic agent for metastatic colorectal cancer in second-line setting—its impact on clinical practice
- (2015) Gaurav Goel et al. Journal of Hematology & Oncology
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- Fibroblast Growth Factor Receptor 1 Gene Copy Number and mRNA Expression in Primary Colorectal Cancer and Its Clinicopathologic Correlation
- (2015) Yoonjin Kwak et al. PATHOBIOLOGY
- Colorectal cancer: Metastases to a single organ
- (2015) Sina Vatandoust WORLD JOURNAL OF GASTROENTEROLOGY
- Identification and characterization of RET fusions in advanced colorectal cancer
- (2015) Anne-France Le Rolle et al. Oncotarget
- AXL is an oncotarget in human colorectal cancer
- (2015) Erika Martinelli et al. Oncotarget
- The emerging role of CaMKII in cancer
- (2015) Yan-yang Wang et al. Oncotarget
- NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line
- (2015) Su Jin Lee et al. Oncotarget
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Inhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack
- (2015) Italia Grenga et al. Journal for ImmunoTherapy of Cancer
- The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy
- (2015) Paolo Giovanni Vigneri et al. Frontiers in Oncology
- Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer
- (2015) Anne-Catherine Lhoumeau et al. PLoS One
- DFGmodel: Predicting Protein Kinase Structures in Inactive States for Structure-Based Discovery of Type-II Inhibitors
- (2014) Peter Man-Un Ung et al. ACS Chemical Biology
- TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis
- (2014) J. H. M. van der Meer et al. BLOOD
- The MAPK pathway across different malignancies: A new perspective
- (2014) Mauricio Burotto et al. CANCER
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- How to select the optimal treatment for first line metastatic colorectal cancer
- (2014) Alexander Stein WORLD JOURNAL OF GASTROENTEROLOGY
- p38α MAPK pathway: A key factor in colorectal cancer therapy and chemoresistance
- (2014) Valentina Grossi WORLD JOURNAL OF GASTROENTEROLOGY
- Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer
- (2014) R C Turkington et al. Cell Death & Disease
- The landscape of kinase fusions in cancer
- (2014) Nicolas Stransky et al. Nature Communications
- The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis
- (2014) Uwe Knippschild et al. Frontiers in Oncology
- Targeting the PDGF signaling pathway in tumor treatment
- (2013) Carl-Henrik Heldin Cell Communication and Signaling
- AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer
- (2013) P. D. Dunne et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: ROS1 Fusion Proteins in Cancer
- (2013) K. D. Davies et al. CLINICAL CANCER RESEARCH
- Expression of HGF and Met in Human Tissues of Colorectal Cancers: Biological and Clinical Implications for Synchronous Liver Metastasis
- (2013) Yan-lai Sun et al. International Journal of Medical Sciences
- ROS1 and ALK Fusions in Colorectal Cancer, with Evidence of Intratumoral Heterogeneity for Molecular Drivers
- (2013) Dara L. Aisner et al. MOLECULAR CANCER RESEARCH
- The Role of Ryk and Ror Receptor Tyrosine Kinases in Wnt Signal Transduction
- (2013) J. Green et al. Cold Spring Harbor Perspectives in Biology
- Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation
- (2012) Alexandre Calon et al. CANCER CELL
- The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis
- (2012) Caroline E. Ford et al. INTERNATIONAL JOURNAL OF CANCER
- RET is a potential tumor suppressor gene in colorectal cancer
- (2012) Y Luo et al. ONCOGENE
- Design principles underpinning the regulatory diversity of protein kinases
- (2012) K. Oruganty et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Involvement of K-RAS mutations and amino acid substitutions in the survival of metastatic colorectal cancer patients
- (2012) Elisabeth Pérez-Ruiz et al. TUMOR BIOLOGY
- Allosteric Modification, the Primary ATP Activation Mechanism of Atrial Natriuretic Factor Receptor Guanylate Cyclase
- (2011) Teresa Duda et al. BIOCHEMISTRY
- Inhibition of HGF/cMET expression prevents distant recurrence of rectal cancer after preoperative chemoradiotherapy
- (2011) Susumu Saigusa INTERNATIONAL JOURNAL OF ONCOLOGY
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Vascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers
- (2010) N. R. Smith et al. CLINICAL CANCER RESEARCH
- HGF Rescues Colorectal Cancer Cells from EGFR Inhibition via MET Activation
- (2010) D. Liska et al. CLINICAL CANCER RESEARCH
- Monoclonal antibodies in the treatment of metastatic colorectal cancer: A review
- (2010) Jolien Tol et al. CLINICAL THERAPEUTICS
- KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- ROS receptor tyrosine kinase: a new potential target for anticancer drugs
- (2010) Ibrahim Mustafa El-Deeb et al. MEDICINAL RESEARCH REVIEWS
- DNA Sequence Profiles of the Colorectal Cancer Critical Gene Set KRAS-BRAF-PIK3CA-PTEN-TP53 Related to Age at Disease Onset
- (2010) Marianne Berg et al. PLoS One
- Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy
- (2009) Thomas R Webb et al. Expert Review of Anticancer Therapy
- The role of Eph receptors and ephrin ligands in colorectal cancer
- (2009) Nirmitha I Herath et al. INTERNATIONAL JOURNAL OF CANCER
- The Linker Region in Receptor Guanylyl Cyclases Is a Key Regulatory Module
- (2009) Sayanti Saha et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer
- (2009) Fotios Loupakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
- (2009) Pierre Laurent-Puig et al. JOURNAL OF CLINICAL ONCOLOGY
- The nuts and bolts of AGC protein kinases
- (2009) Laura R. Pearce et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Tenets of PTEN Tumor Suppression
- (2008) Leonardo Salmena et al. CELL
- Ca2+/Calmodulin-dependent Protein Kinases
- (2008) M. T. Swulius et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Expression and Function of Bcl-2 Proteins in Melanoma
- (2008) Jurgen Eberle et al. CURRENT GENOMICS
- ExplorEnz: the primary source of the IUBMB enzyme list
- (2008) A. G. McDonald et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search